EMA: Regulatory Guidance Hinders Development of ATMPs By Sam | February 3, 2017 Advanced therapy medical products are facing several development hurdles, ranging from inadequate regulatory guidance to insufficient funding, the EMA said. Source: Drug Industry Daily Posted in Drug Industry Daily